Nov 07, 2024 / 01:30PM GMT
Operator
Good morning, ladies and gentlemen, my name is Chester and I will be your operator for today.
Welcome to Night Therapeutics third quarter, 2024 results conference call before turning the call over to Samira Saka, President NCO of Night listeners are reminded that portions of the day's discussion may by their nature necessarily involve risk and uncertainties that could cause actual results to differ material from those contemplated by the forward-looking statements.
The company considers the assumption on which these forward booking statements are based to be reasonable at the time they were prepared but cautions cautions that this assumption regarding the future events, many of which are beyond the control of the company and its subsidiaries may ultimately prove to be incorrect.
The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events except as required by law.
We would also like to remind you questions during today's call will be taken from analysts only.
Should
Q3 2024 Knight Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot